Ethyl 6-heptenoate

CAS No. 25118-23-4

Ethyl 6-heptenoate( —— )

Catalog No. M37386 CAS No. 25118-23-4

Ethyl 6-heptenoate (6-Heptenoic acid ethyl ester) has some neurotoxicity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 37 In Stock
100MG 53 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ethyl 6-heptenoate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ethyl 6-heptenoate (6-Heptenoic acid ethyl ester) has some neurotoxicity.
  • Description
    Ethyl 6-heptenoate (6-Heptenoic acid ethyl ester) has some neurotoxicity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    25118-23-4
  • Formula Weight
    156.22
  • Molecular Formula
    C9H16O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC(=O)CCCCC=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NP-G2-044

    NP-G2-044 is an orally active fascin inhibitor, with an IC50 of ~2 μM. It blocks tumor metastasis and increases antitumor immune response.

  • Falcarinol

    Falcarinol, also known as Panaxynol, is a naturally occurring compound that acts as an orally active inhibitor of Hsp90.

  • Chitinase, Serratia ...

    Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human fibrotic and inflammatory disorders, particularly those of the lung (idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, sarcoidosis, and asthma) and the gastrointestinal tract (inflammatory bowel diseases (IBDs) and colon cancer).